Calcineurin?NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Prolonged cardiac hypertrophy of pathologic etiology is associated with arrhythmia, sudden death, decompensation, and dilated cardiomyopathy. In an attempt to understand the mechanisms that underlie the hypertrophic response, extensive investigation has centered on a characterization of the molecular pathways that initiate or maintain the pathologic growth of individual cardiac myocytes. While a large number of signal transduction cascades have been identified as critical regulators of cardiac hypertrophy, here the scientific evidence implicating the protein phosphatase calcineurin (PP2B) and the mitogen-activated protein kinases (MAPK) as co-regulators of reactive hypertrophy will be discussed. Gain- and loss-of-function studies in genetically altered mice and in cultured cardiomyocytes have demonstrated the necessity and sufficiency of calcineurin to regulate pathologic cardiac hypertrophy. However, using similar approaches, the hypertrophic regulatory role attributed to various branches of the MAPK signaling pathway has been less conclusive, although a loose consensus suggests that the c-Jun N-terminal kinases (JNK) and p38 kinases function as mediators of dilated cardiomyopathy, while extracellular signal-regulated kinases (ERKs) function as regulators of hypertrophy. More recently, the actions of calcineurin and MAPK signaling pathways have been shown to be co-dependent such that unitary activation of calcineurin in myocytes leads to up-regulation in ERK and JNK signaling, but down-regulation in p38 signaling. Conversely, unitary activation of JNK or p38 in cardiac myocytes leads to down-regulation of calcineurin effectiveness by directly antagonizing nuclear factor of activated T cells (NFAT) nuclear occupancy. Thus, an emerging paradigm suggests that calcineurin-NFAT and MAPK signaling pathways are inter-dependent and together orchestrate the cardiac hypertrophic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Self-citationThe epidemiology of heart failure: The Framingham Study
Ho, K. K. L., Pinsky, J. L., Kannel, W. B., & Levy, D. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90455-a · Cited by 2,247
Transcriptional regulation by calcium, calcineurin, and NFAT
Hogan, P. G., Chen, L., Nardone, J., & Rao, A. (2003) · Genes & Development · doi:10.1101/gad.1102703 · Cited by 1,991 · cited 3×
“For example, NFAT-dependent cytokine gene expression also depends on direct interaction with the inducible transcriptional regulator AP-1, which is directly regulated by JNK phosphorylation [10].”
BackgroundInfluentialDifferential activation of transcription factors induced by Ca2+ response amplitude and duration
Dolmetsch, R. E., Lewis, R. S., Goodnow, C. C., & Healy, J. I. (1997) · Nature · doi:10.1038/40912 · Cited by 1,521
Organization and regulation of mitogen-activated protein kinase signaling pathways
Garrington, T. P., & Johnson, G. L. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80028-3 · Cited by 1,275
Regulation of the Calmodulin-stimulated Protein Phosphatase, Calcineurin
Klee, C. B., Ren, H., & Wang, X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13367 · Cited by 898
PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., et al. (2000) · Nature · doi:10.1038/35006090 · Cited by 892
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice
Bueno, O. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6341 · Cited by 774
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy
Wilkins, B. J., Dai, Y.-S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., Jones, F., Kimball, T. R., & Molkentin, J. D. (2004) · Circulation Research · doi:10.1161/01.res.0000109415.17511.18 · Cited by 761
Self-citationNuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3
Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P., & Crabtree, G. R. (1997) · Science · doi:10.1126/science.275.5308.1930 · Cited by 754
Generic Signals and Specific Outcomes
Crabtree, G. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80571-1 · Cited by 731
Association of Protein Kinase A and Protein Phosphatase 2B with a Common Anchoring Protein
Coghlan, V. M., Perrino, B. A., Howard, M., Langeberg, L. K., Hicks, J. B., Gallatin, W. M., & Scott, J. D. (1995) · Science · doi:10.1126/science.7528941 · Cited by 617
Sugden, P. H., & Clerk, A. (1998) · Circulation Research · doi:10.1161/01.res.83.4.345 · Cited by 513
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition
Sussman, M. A., Lim, H. W., Gude, N., Taigen, T., Olson, E. N., Robbins, J., Colbert, M. C., Gualberto, A., Wieczorek, D. F., & Molkentin, J. D. (1998) · Science · doi:10.1126/science.281.5383.1690 · Cited by 461
Self-citationDSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways
Fuentes, J. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.11.1681 · Cited by 461
Haq, S., Choukroun, G., Lim, H., Tymitz, K. M., del Monte, F., Gwathmey, J., Grazette, L., Michael, A., Hajjar, R., Force, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.5.670 · Cited by 440
Self-citationRothermel, B., Vega, R. B., Yang, J., Wu, H., Bassel-Duby, R., & Williams, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8719 · Cited by 414
Involvement of Extracellular Signal-Regulated Kinases 1/2 in Cardiac Hypertrophy and Cell Death
Bueno, O. F., & Molkentin, J. D. (2002) · Circulation Research · doi:10.1161/01.res.0000038488.38975.1a · Cited by 397
Self-citationGlycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
Haq, S., Choukroun, G., Kang, Z. B., Ranu, H., Matsui, T., Rosenzweig, A., Molkentin, J. D., Alessandrini, A., Woodgett, J., Hajjar, R., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.1.117 · Cited by 392
Self-citationNuclear Accumulation of NFAT4 Opposed by the JNK Signal Transduction Pathway
Chow, C.-W., Rincón, M., Cavanagh, J., Dickens, M., & Davis, R. J. (1997) · Science · doi:10.1126/science.278.5343.1638 · Cited by 357
The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
Liao, P., Georgakopoulos, D., Kovacs, A., Zheng, M., Lerner, D., Pu, H., Saffitz, J., Chien, K., Xiao, R.-P., Kass, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211086598 · Cited by 333
Braz, J. C., Bueno, O. F., Liang, Q., Wilkins, B. J., Dai, Y.-S., Parsons, S., Braunwart, J., Glascock, B. J., Klevitsky, R., Kimball, T. F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17295 · Cited by 332
Self-citationJNK is required for effector T-cell function but not for T-cell activation
Dong, C., Yang, D. D., Tournier, C., Whitmarsh, A. J., Xu, J., Davis, R. J., & Flavell, R. A. (2000) · Nature · doi:10.1038/35011091 · Cited by 328
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload
Hill, J. A., Karimi, M., Kutschke, W., Davisson, R. L., Zimmerman, K., Wang, Z., Kerber, R. E., & Weiss, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.24.2863 · Cited by 309
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T., De Windt, L. J., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Self-citationMyocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
Fiedler, B., Lohmann, S. M., Smolenski, A., Linnemüller, S., Pieske, B., Schröder, F., Molkentin, J. D., Drexler, H., & Wollert, K. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162100799 · Cited by 276
Self-citationWilkins, B. J., De Windt, L. J., Bueno, O. F., Braz, J. C., Glascock, B. J., Kimball, T. F., & Molkentin, J. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7603-7613.2002 · Cited by 262
Self-citationMende, U., Kagen, A., Cohen, A., Aramburu, J., Schoen, F. J., & Neer, E. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13893 · Cited by 258
Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter
Sanbe, A., Gulick, J., Hanks, M. C., Liang, Q., Osinska, H., & Robbins, J. (2003) · Circulation Research · doi:10.1161/01.res.0000065442.64694.9f · Cited by 249
Cabin 1, A Negative Regulator for Calcineurin Signaling in T Lymphocytes
Sun, L., Youn, H.-D., Loh, C., Stolow, M., He, W., & Liu, J. O. (1998) · Immunity · doi:10.1016/s1074-7613(00)80575-0 · Cited by 242
Liang, Q. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.10.001 · Cited by 238
Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072647999 · Cited by 237
Self-citationNemoto, S., Sheng, Z., & Lin, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3518 · Cited by 230
Cain, A Novel Physiologic Protein Inhibitor of Calcineurin
Lai, M. M., Burnett, P. E., Wolosker, H., Blackshaw, S., & Snyder, S. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18325 · Cited by 230
An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy
Fatkin, D., McConnell, B. K., Mudd, J. O., Semsarian, C., Moskowitz, I. G. P., Schoen, F. J., Giewat, M., Seidman, C. E., & Seidman, J. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11093 · Cited by 228
Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the Heart
De Windt, L. J., Lim, H. W., Haq, S., Force, T., & Molkentin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13571 · Cited by 226
Self-citationDe Windt, L. J., Lim, H. W., Taigen, T., Wencker, D., Condorelli, G., Dorn, G. W., Kitsis, R. N., & Molkentin, J. D. (2000) · Circulation Research · doi:10.1161/01.res.86.3.255 · Cited by 225
Self-citationTargeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
De Windt, L. J., Lim, H. W., Bueno, O. F., Liang, Q., Delling, U., Braz, J. C., Glascock, B. J., Kimball, T. F., del Monte, F., Hajjar, R. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031371998 · Cited by 202
Self-citationLiang, Q. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg474 · Cited by 197
Defective T cell development and function in calcineurin Aβ-deficient mice
Bueno, O. F., Brandt, E. B., Rothenberg, M. E., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152665399 · Cited by 188
Self-citationMeguro, T., Hong, C., Asai, K., Takagi, G., McKinsey, T. A., Olson, E. N., & Vatner, S. F. (1999) · Circulation Research · doi:10.1161/01.res.84.6.735 · Cited by 181
Phosphorylation of NFATc4 by p38 Mitogen-Activated Protein Kinases
Yang, T. T. C., Xiong, Q., Enslen, H., Davis, R. J., & Chow, C.-W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3892-3904.2002 · Cited by 174
β-Adrenergic Pathway Induces Apoptosis through Calcineurin Activation in Cardiac Myocytes
Saito, S., Hiroi, Y., Zou, Y., Aikawa, R., Toko, H., Shibasaki, F., Yazaki, Y., Nagai, R., & Komuro, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002844200 · Cited by 166
Multiple p21ras effector pathways regulate nuclear factor of activated T cells.
Genot, E., Cleverley, S., Henning, S., & Cantrell, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00766.x · Cited by 163
Calcineurin Plays a Critical Role in Pressure Overload–Induced Cardiac Hypertrophy
Shimoyama, M., Hayashi, D., Takimoto, E., Zou, Y., Oka, T., Uozumi, H., Kudoh, S., Shibasaki, F., Yazaki, Y., Nagai, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.24.2449 · Cited by 163
A Role for the p38 MAP Kinase Pathway in the Nuclear Shuttling of NFATp
del Arco, P. G., Martı́nez-Martı́nez, S., Maldonado, J. L., Ortega-Pérez, I., & Redondo, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13872 · Cited by 159
Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy
Lim, H. W., De Windt, L. J., Steinberg, L., Taigen, T., Witt, S. A., Kimball, T. R., & Molkentin, J. D. (2000) · Circulation · doi:10.1161/01.cir.101.20.2431 · Cited by 158
Self-citationDing, B., Price, R. L., Borg, T. K., Weinberg, E. O., Halloran, P. F., & Lorell, B. H. (1999) · Circulation Research · doi:10.1161/01.res.84.6.729 · Cited by 153
Porter, C. M., Havens, M. A., & Clipstone, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3543 · Cited by 151
T cell responses in calcineurin A alpha-deficient mice.
Zhang, B. W., Zimmer, G., Chen, J., Ladd, D., Li, E., Alt, F. W., Wiederrecht, G., Cryan, J., O'Neill, E. A., Seidman, C. E., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.413 · Cited by 150
Zou, Y., Yao, A., Zhu, W., Kudoh, S., Hiroi, Y., Shimoyama, M., Uozumi, H., Kohmoto, O., Takahashi, T., Shibasaki, F., et al. (2001) · Circulation · doi:10.1161/hc2601.090987 · Cited by 146
Failure of Calcineurin Inhibitors to Prevent Pressure-Overload Left Ventricular Hypertrophy in Rats
Zhang, W., Kowal, R. C., Rusnak, F., Sikkink, R. A., Olson, E. N., & Victor, R. G. (1999) · Circulation Research · doi:10.1161/01.res.84.6.722 · Cited by 142
c-Jun N-Terminal Kinase Activation Mediates Downregulation of Connexin43 in Cardiomyocytes
Petrich, B. G., Gong, X., Lerner, D. L., Wang, X., Brown, J. H., Saffitz, J. E., & Wang, Y. (2002) · Circulation Research · doi:10.1161/01.res.0000035854.11082.01 · Cited by 141
Calcineurin and human heart failure
Lim, H. W., & Molkentin, J. D. (1999) · Nature Medicine · doi:10.1038/6430 · Cited by 131
Self-citationZou, Y., Hiroi, Y., Uozumi, H., Takimoto, E., Toko, H., Zhu, W., Kudoh, S., Mizukami, M., Shimoyama, M., Shibasaki, F., et al. (2001) · Circulation · doi:10.1161/01.cir.104.1.97 · Cited by 131
Kakita, T., Hasegawa, K., Iwai‐Kanai, E., Adachi, S., Morimoto, T., Wada, H., Kawamura, T., Yanazume, T., & Sasayama, S. (2001) · Circulation Research · doi:10.1161/hh1201.091794 · Cited by 131
AT 1 Receptor Blockade Reduces Cardiac Calcineurin Activity in Hypertensive Rats
Nagata, K., Somura, F., Obata, K., Odashima, M., Izawa, H., Ichihara, S., Nagasaka, T., Iwase, M., Yamada, Y., Nakashima, N., et al. (2002) · Hypertension · doi:10.1161/01.hyp.0000026668.50222.1e · Cited by 109
Pu, W. T., Ma, Q., & Izumo, S. (2003) · Circulation Research · doi:10.1161/01.res.0000069211.82346.46 · Cited by 102
Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy
Takeda, Y., Yoneda, T., Demura, M., Usukura, M., & Mabuchi, H. (2002) · Circulation · doi:10.1161/hc0602.104675 · Cited by 97
Ras Regulates NFAT3 Activity in Cardiac Myocytes
Ichida, M., & Finkel, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004275200 · Cited by 95
Na+-Ca2+ Exchanger Remodeling in Pressure Overload Cardiac Hypertrophy
Wang, Z., Nolan, B., Kutschke, W. J., & Hill, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100544200 · Cited by 94
Distinct tissue and cellular distribution of two major isoforms of calcineurin
Jiang, H., Xiong, F., Kong, S., Ogawa, T., Kobayashi, M., & Liu, J. O. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00054-0 · Cited by 94
Reversal of Cardiac Hypertrophy in Transgenic Disease Models by Calcineurin Inhibition
Lim, H. W., Windt, L. J. D., Mante, J., Kimball, T. R., Witt, S. A., Sussman, M. A., & Molkentin, J. D. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1113 · Cited by 90
Self-citationBueno, O. F., Lips, D. J., Kaiser, R. A., Wilkins, B. J., Dai, Y., Glascock, B. J., Klevitsky, R., Hewett, T. E., Kimball, T. R., Aronow, B. J., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000107197.99679.77 · Cited by 90
Self-citationMuramatsu, T., Giri, P. R., Higuchi, S., & Kincaid, R. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.529 · Cited by 85
Sakata, Y., Masuyama, T., Yamamoto, K., Nishikawa, N., Yamamoto, H., Kondo, H., Ono, K., Otsu, K., Kuzuya, T., Miwa, T., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2269 · Cited by 84
Petrich, B. G., Molkentin, J. D., & Wang, Y. (2003) · The FASEB Journal · doi:10.1096/fj.02-0438fje · Cited by 83
Self-citationMervaala, E. M. A., Müller, D. N., Park, J.-K., Dechend, R., Schmidt, F. H., Fiebeler, A., Bieringer, M., Breu, V., Ganten, D., Haller, H. G., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.360 · Cited by 81
Calcineurin in Human Heart Hypertrophy
Ritter, O., Hack, S., Schuh, K., Röthlein, N., Perrot, A., Osterziel, K. J., Schulte, H. D., & Neyses, L. (2002) · Circulation · doi:10.1161/01.cir.0000016044.19527.96 · Cited by 79
Eto, Y., Yonekura, K., Sonoda, M., Arai, N., Sata, M., Sugiura, S., Takenaka, K., Gualberto, A., Hixon, M. L., Wagner, M. W., et al. (2000) · Circulation · doi:10.1161/01.cir.101.18.2134 · Cited by 77
Øie, E., Bjørnerheim, R., Clausen, O. P. F., & Attramadal, H. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h2115 · Cited by 71
Takaishi, T., Saito, N., Kuno, T., & Tanaka, C. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90533-d · Cited by 66
Calcineurin Inhibition and Cardiac Hypertrophy
Müller, J. G., Nemoto, S., Laser, M., Carabello, B. A., & Menick, D. R. (1998) · Science · doi:10.1126/science.282.5391.1007a · Cited by 56
Shimoyama, M., Hayashi, D., Zou, Y., Takimoto, E., Mizukami, M., Monzen, K., Kudoh, S., Hiroi, Y., Yazaki, Y., Nagai, R., et al. (2000) · Circulation · doi:10.1161/01.cir.102.16.1996 · Cited by 50
Deng, L., Huang, B., Qin, D., Ganguly, K., & El‐Sherif, N. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.01055.x · Cited by 44
Li, J. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00471-1 · Cited by 11
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Self-citationCalcium Cycling and Signaling in Cardiac Myocytes
Bers, D. M. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100455 · Cited by 1,302
Rose, B. A., Force, T., & Wang, Y. (2010) · Physiological Reviews · doi:10.1152/physrev.00054.2009 · Cited by 723
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Carvajal-Vergara, X., Sevilla, A., D’Souza, S. L., Ang, Y.-S., Schaniel, C., Lee, D.-F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R., et al. (2010) · Nature · doi:10.1038/nature09005 · Cited by 690
Metadata
- Authors
- MOLKENTIN, J.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08
- Volume
- 63
- Issue
- 3
- Pages
- 467-475
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2112484130
- Cited by
- 497
- References
- 80
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.